MeSH term
Frequency | Condition_Probility | Animals | 343 | 0.0 |
Humans | 551 | 0.0 |
Oligonucleotide Array Sequence Analysis | 5 | 0.0 |
Aged | 9 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Fatal Outcome | 2 | 0.0 |
Female | 50 | 0.0 |
Swine | 2 | 0.0 |
Cytokines/pharmacology | 7 | 1.0 |
DNA/*metabolism | 2 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Disease Models, Animal | 5 | 0.0 |
Mice | 176 | 0.0 |
Mice, Inbred BALB C | 11 | 0.0 |
Phosphoproteins/*metabolism | 18 | 3.0 |
Protein-Tyrosine Kinase/*metabolism | 143 | 17.0 |
*Proto-Oncogene Proteins | 345 | 20.0 |
Research Support, Non-U.S. Gov't | 407 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 27 | 0.0 |
Signal Transduction/*physiology | 53 | 4.0 |
Trans-Activation (Genetics)/drug effects | 5 | 2.0 |
Transcription Factors/*metabolism | 8 | 0.0 |
Tumor Cells, Cultured | 106 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 14 | 2.0 |
DNA-Binding Proteins/physiology | 10 | 3.0 |
Gene Expression Regulation/physiology | 3 | 1.0 |
Human Growth Hormone/*physiology | 3 | 33.0 |
Liver/metabolism | 6 | 0.0 |
*Milk Proteins | 122 | 26.0 |
Mitogen-Activated Protein Kinases/physiology | 3 | 2.0 |
Promoter Regions (Genetics)/genetics | 4 | 0.0 |
Protein-Tyrosine Kinase/physiology | 21 | 17.0 |
Receptor, Insulin/physiology | 2 | 16.0 |
Receptors, Somatotropin/physiology | 4 | 80.0 |
Research Support, U.S. Gov't, P.H.S. | 227 | 0.0 |
Trans-Activators/physiology | 15 | 10.0 |
*Adaptor Proteins, Signal Transducing | 31 | 2.0 |
*Adaptor Proteins, Vesicular Transport | 12 | 4.0 |
Dimerization | 20 | 1.0 |
Dose-Response Relationship, Drug | 31 | 0.0 |
Male | 48 | 0.0 |
Phosphoproteins/metabolism | 15 | 2.0 |
Phosphorylation/drug effects | 38 | 4.0 |
Phosphotyrosine/analysis | 3 | 5.0 |
Prolactin/pharmacology | 7 | 18.0 |
Protein Processing, Post-Translational/drug effects | 5 | 4.0 |
Protein-Tyrosine Kinase/metabolism | 114 | 12.0 |
Proteins/metabolism | 36 | 3.0 |
Signal Transduction/*drug effects | 29 | 8.0 |
DNA-Binding Proteins/*metabolism | 81 | 3.0 |
Enzyme Activation/drug effects | 34 | 3.0 |
Interleukin-10/*pharmacology | 2 | 2.0 |
JNK Mitogen-Activated Protein Kinases | 6 | 1.0 |
Mitogen-Activated Protein Kinases/*metabolism | 11 | 2.0 |
Phosphorylation | 272 | 3.0 |
Rats | 84 | 0.0 |
Signal Transduction/drug effects | 17 | 2.0 |
Trans-Activators/*metabolism | 85 | 8.0 |
p38 Mitogen-Activated Protein Kinases | 11 | 1.0 |
*Chromosome Aberrations | 2 | 0.0 |
Hodgkin Disease/*genetics/pathology | 2 | 22.0 |
Mutation | 27 | 0.0 |
Endothelium, Vascular/cytology/*metabolism | 2 | 1.0 |
Enzyme Activation | 93 | 2.0 |
Gene Transfer Techniques | 3 | 0.0 |
Signal Transduction/physiology | 16 | 1.0 |
Amino Acid Sequence | 77 | 0.0 |
Molecular Sequence Data | 108 | 0.0 |
Receptors, Interleukin/*chemistry | 2 | 28.0 |
3T3 Cells | 28 | 1.0 |
Fibroblasts/cytology/physiology | 2 | 2.0 |
Interferon Type II/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 21 | 2.0 |
Phosphoserine/*metabolism | 2 | 7.0 |
*Protein-Serine-Threonine Kinases | 9 | 1.0 |
Proto-Oncogene Proteins/metabolism | 14 | 1.0 |
Cells, Cultured | 75 | 0.0 |
*Intercellular Signaling Peptides and Proteins | 2 | 0.0 |
RNA, Messenger/metabolism | 9 | 0.0 |
Recombinant Fusion Proteins/pharmacology | 4 | 4.0 |
Reverse Transcriptase Polymerase Chain Reaction | 18 | 0.0 |
Signal Transduction | 140 | 2.0 |
Amino Acid Motifs | 2 | 0.0 |
Cell Division | 32 | 0.0 |
Cell Line | 174 | 0.0 |
Genes, myc | 3 | 1.0 |
*Neoplasm Proteins | 14 | 1.0 |
Protein-Tyrosine Kinase/*physiology | 23 | 17.0 |
*Receptors, Cytokine | 10 | 7.0 |
Structure-Activity Relationship | 21 | 0.0 |
Thrombopoietin/pharmacology | 5 | 9.0 |
Tyrosine/metabolism | 74 | 6.0 |
COS Cells | 29 | 1.0 |
Carrier Proteins/genetics/*metabolism | 3 | 0.0 |
Cell Fractionation | 5 | 1.0 |
Cysteine Endopeptidases/*metabolism | 2 | 0.0 |
Interferon Type II/pharmacology | 9 | 1.0 |
Interleukin-3/pharmacology | 14 | 5.0 |
*Intracellular Signaling Peptides and Proteins | 29 | 4.0 |
Leupeptins/pharmacology | 3 | 2.0 |
Multienzyme Complexes/antagonists & inhibitors/*metabolism | 2 | 9.0 |
Proteasome Endopeptidase Complex | 3 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 9 | 6.0 |
Repressor Proteins/metabolism | 5 | 2.0 |
Signal Transduction/drug effects/physiology | 10 | 4.0 |
Tyrosine/*metabolism | 25 | 7.0 |
Ubiquitin/*metabolism | 3 | 1.0 |
Genes, Reporter | 17 | 0.0 |
Mutagenesis, Site-Directed | 24 | 0.0 |
Protein Structure, Tertiary | 15 | 0.0 |
Trans-Activation (Genetics) | 15 | 0.0 |
Transcription, Genetic | 28 | 0.0 |
src-Family Kinases/*metabolism | 4 | 2.0 |
Antigens, CD/metabolism | 10 | 1.0 |
DNA-Binding Proteins/metabolism | 81 | 4.0 |
Down-Regulation | 9 | 0.0 |
Enzyme Inhibitors/pharmacology | 55 | 2.0 |
Kinetics | 35 | 0.0 |
Membrane Glycoproteins/metabolism | 6 | 1.0 |
Protein-Tyrosine-Phosphatase/antagonists & inhibitors | 2 | 5.0 |
*Signal Transduction/drug effects | 9 | 9.0 |
English Abstract | 7 | 0.0 |
Erythropoietin/pharmacology | 9 | 7.0 |
Precipitin Tests | 38 | 1.0 |
Receptors, Erythropoietin/*physiology | 3 | 21.0 |
Trans-Activators/metabolism | 91 | 9.0 |
DNA-Binding Proteins/*physiology | 12 | 2.0 |
Gene Expression Regulation/drug effects/physiology | 3 | 4.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology | 10 | 6.0 |
Immediate-Early Proteins/genetics | 3 | 6.0 |
Macrophages/cytology/*physiology | 3 | 23.0 |
Trans-Activators/*physiology | 13 | 5.0 |
Endothelium, Vascular/cytology | 2 | 0.0 |
Interferon Type II/*pharmacology | 22 | 5.0 |
*Nuclear Proteins | 2 | 0.0 |
Receptors, Interferon/biosynthesis | 2 | 40.0 |
Mice, Knockout | 9 | 0.0 |
Receptor, Epidermal Growth Factor/*physiology | 2 | 1.0 |
Cell Differentiation | 16 | 0.0 |
Interleukin-5/*pharmacology | 10 | 31.0 |
Phosphotyrosine/metabolism | 45 | 10.0 |
Protein Subunits | 2 | 0.0 |
Receptors, Interleukin/metabolism | 4 | 6.0 |
Amino Acid Substitution | 2 | 0.0 |
Cell Division/drug effects/physiology | 5 | 1.0 |
Mice, Transgenic | 6 | 0.0 |
Receptors, Erythropoietin/genetics/*physiology | 2 | 50.0 |
Acute Disease | 4 | 0.0 |
Adolescent | 6 | 0.0 |
Blotting, Southern | 4 | 0.0 |
DNA Primers/chemistry | 3 | 0.0 |
Genes, abl/*genetics | 2 | 11.0 |
In Situ Hybridization, Fluorescence | 11 | 0.0 |
Oncogene Proteins/genetics | 2 | 2.0 |
*Philadelphia Chromosome | 2 | 2.0 |
Blotting, Northern | 7 | 0.0 |
Blotting, Western | 41 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors | 11 | 5.0 |
Cytokines/*physiology | 4 | 2.0 |
Growth Hormone/*physiology | 5 | 19.0 |
Immunoblotting | 14 | 0.0 |
Receptors, Somatotropin/metabolism | 10 | 43.0 |
Up-Regulation/*drug effects | 2 | 2.0 |
Apoptosis/drug effects | 10 | 1.0 |
Carrier Proteins/physiology | 3 | 2.0 |
Cell Division/drug effects | 37 | 1.0 |
DNA-Binding Proteins/genetics | 4 | 0.0 |
Gene Expression | 17 | 0.0 |
Leptin/*metabolism/pharmacology | 2 | 100.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 13 | 3.0 |
Mitogen-Activated Protein Kinase 3 | 19 | 3.0 |
Proteins/genetics | 9 | 1.0 |
RNA, Messenger/analysis | 12 | 0.0 |
*Receptors, Cell Surface | 6 | 1.0 |
Recombinant Proteins | 5 | 0.0 |
*Repressor Proteins | 35 | 3.0 |
*Signal Transduction | 90 | 4.0 |
Trans-Activators/genetics | 4 | 1.0 |
*Transcription Factors | 15 | 0.0 |
Transfection | 116 | 0.0 |
Hela Cells | 11 | 0.0 |
Receptors, Cytokine/*metabolism | 6 | 7.0 |
Up-Regulation | 4 | 0.0 |
Receptors, Erythropoietin/*metabolism | 4 | 23.0 |
Apoptosis | 7 | 0.0 |
Cell Lineage | 4 | 0.0 |
Cell Nucleus/metabolism | 20 | 1.0 |
Cell Survival | 7 | 0.0 |
Chromones/pharmacology | 7 | 3.0 |
Flow Cytometry | 8 | 0.0 |
Genes, Dominant | 6 | 0.0 |
Luciferases/metabolism | 9 | 1.0 |
Microscopy, Confocal | 5 | 0.0 |
Morpholines/pharmacology | 7 | 2.0 |
NF-kappa B/metabolism | 4 | 0.0 |
Promoter Regions (Genetics) | 14 | 0.0 |
Protein Binding | 44 | 0.0 |
Time Factors | 29 | 0.0 |
Granulocyte Colony-Stimulating Factor/pharmacology | 2 | 1.0 |
Recombinant Fusion Proteins | 3 | 0.0 |
Tyrosine | 7 | 6.0 |
Carrier Proteins/*metabolism | 6 | 0.0 |
DNA, Complementary/metabolism | 6 | 0.0 |
*Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Plasmids/metabolism | 7 | 0.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Butadienes/pharmacology | 3 | 5.0 |
Imidazoles/pharmacology | 3 | 1.0 |
Interleukin-13/*metabolism | 2 | 16.0 |
Interleukin-4/*metabolism | 3 | 7.0 |
Ligands | 14 | 0.0 |
Nitriles/pharmacology | 6 | 5.0 |
Pyridines/pharmacology | 2 | 0.0 |
Tyrphostins/pharmacology | 25 | 16.0 |
MAP Kinase Signaling System | 8 | 3.0 |
Models, Biological | 20 | 0.0 |
Erythropoietin/metabolism/pharmacology | 3 | 37.0 |
Receptors, Cell Surface/metabolism | 4 | 0.0 |
Receptors, Erythropoietin/chemistry/*metabolism | 3 | 60.0 |
Cell Line, Tumor | 18 | 0.0 |
Fibroblasts | 6 | 1.0 |
Gene Deletion | 6 | 0.0 |
Protein-Tyrosine-Phosphatase/metabolism | 9 | 7.0 |
Vanadates/pharmacology | 5 | 3.0 |
DNA-Binding Proteins/analysis | 3 | 3.0 |
*Gene Expression | 2 | 0.0 |
Trans-Activators/analysis | 2 | 6.0 |
Base Sequence | 81 | 0.0 |
*Chromosomes, Human, Pair 12 | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 5 | 0.0 |
Middle Aged | 10 | 0.0 |
Oncogene Proteins, Fusion/*genetics | 5 | 2.0 |
*Protein-Tyrosine Kinase | 4 | 1.0 |
Repressor Proteins/*genetics | 2 | 0.0 |
*Translocation, Genetic | 3 | 0.0 |
DNA/metabolism | 18 | 1.0 |
Endothelium, Vascular/metabolism | 2 | 0.0 |
Genistein/pharmacology | 6 | 5.0 |
*Oxidative Stress | 2 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/*metabolism | 7 | 12.0 |
Gene Expression Profiling | 3 | 0.0 |
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/*metabolism | 4 | 44.0 |
Carrier Proteins/pharmacology | 2 | 3.0 |
Caseins/genetics | 2 | 18.0 |
Prolactin/*physiology | 4 | 10.0 |
Promoter Regions (Genetics)/drug effects | 2 | 1.0 |
Proteins/pharmacology | 2 | 3.0 |
Receptors, Prolactin/*metabolism | 4 | 16.0 |
Protein-Tyrosine Kinase/chemistry/*metabolism | 2 | 5.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 8 | 6.0 |
Proteins/chemistry/*metabolism | 2 | 2.0 |
Sequence Homology, Amino Acid | 22 | 0.0 |
Substrate Specificity | 9 | 0.0 |
Adult | 14 | 0.0 |
Caseins/metabolism | 2 | 9.0 |
Gene Expression Regulation/drug effects/*immunology | 2 | 6.0 |
Phosphoproteins/genetics | 2 | 1.0 |
RNA, Messenger/drug effects/metabolism | 2 | 1.0 |
Signal Transduction/drug effects/*immunology | 5 | 13.0 |
Trans-Activators/drug effects/metabolism | 2 | 9.0 |
Cell Membrane/metabolism | 5 | 0.0 |
Cyclodextrins/pharmacology | 2 | 7.0 |
DNA-Binding Proteins/genetics/*metabolism | 15 | 1.0 |
Fibroblasts/metabolism | 4 | 0.0 |
Trans-Activators/genetics/*metabolism | 15 | 4.0 |
*beta-Cyclodextrins | 2 | 4.0 |
Apoptosis/*physiology | 2 | 0.0 |
Flavonoids/pharmacology | 10 | 3.0 |
Human Growth Hormone/*pharmacology | 16 | 42.0 |
Hydrogen Peroxide/pharmacology | 2 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Naphthalenes/pharmacology | 3 | 3.0 |
Oxidants/pharmacology | 2 | 3.0 |
Oxidative Stress | 2 | 0.0 |
Proto-Oncogene Proteins c-raf/metabolism | 4 | 4.0 |
Rats, Wistar | 6 | 0.0 |
ras Proteins/metabolism | 8 | 5.0 |
src-Family Kinases/metabolism | 5 | 2.0 |
Antineoplastic Agents/*pharmacology | 6 | 0.0 |
DNA, Neoplasm/biosynthesis | 2 | 1.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors/metabolism | 6 | 14.0 |
Tumor Stem Cell Assay | 3 | 1.0 |
Tyrphostins/*pharmacology | 4 | 16.0 |
Interferon Type II/*metabolism | 4 | 6.0 |
Recombinant Fusion Proteins/metabolism | 15 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Erythropoietin/*pharmacology | 13 | 11.0 |
Hematopoietic Stem Cells/metabolism | 2 | 1.0 |
K562 Cells | 3 | 0.0 |
Phosphotyrosine/*metabolism | 5 | 8.0 |
Growth Hormone/*pharmacology | 21 | 28.0 |
Protein Isoforms | 2 | 0.0 |
Rats, Sprague-Dawley | 15 | 0.0 |
Recombinant Proteins/metabolism | 17 | 0.0 |
Cloning, Molecular | 27 | 0.0 |
Growth Substances/*pharmacology | 2 | 0.0 |
Macaca mulatta | 2 | 0.0 |
Proto-Oncogene Proteins/physiology | 3 | 2.0 |
Receptors, Cytokine/metabolism | 8 | 8.0 |
Thrombopoietin/*physiology | 3 | 15.0 |
CHO Cells/metabolism | 2 | 5.0 |
Cell Transformation, Neoplastic/*metabolism | 2 | 5.0 |
Hamsters | 30 | 0.0 |
Kidney/cytology | 2 | 1.0 |
*MAP Kinase Kinase Kinase 1 | 2 | 1.0 |
Mitogen-Activated Protein Kinase 8 | 3 | 3.0 |
Protein-Serine-Threonine Kinases/metabolism | 10 | 1.0 |
Rats, Inbred BUF | 2 | 9.0 |
Serine/*metabolism | 2 | 2.0 |
Transcription Factors/metabolism | 14 | 0.0 |
rhoA GTP-Binding Protein/*metabolism | 2 | 3.0 |
Fusion Proteins, bcr-abl/*metabolism | 3 | 8.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Mice, Nude | 3 | 0.0 |
Cell Differentiation/drug effects | 7 | 0.0 |
Cytoplasm/chemistry | 2 | 1.0 |
Hematopoietic Stem Cells/cytology/*drug effects | 5 | 9.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Protein Transport | 5 | 0.0 |
Trans-Activators/pharmacology/physiology | 2 | 100.0 |
Recombinant Fusion Proteins/chemistry | 2 | 2.0 |
*Gene Expression Profiling | 2 | 0.0 |
Protein-Tyrosine Kinase/genetics/physiology | 2 | 13.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/metabolism | 2 | 2.0 |
Cell Cycle/drug effects | 5 | 0.0 |
Cell Survival/drug effects/physiology | 4 | 4.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 2 | 2.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/metabolism | 8 | 12.0 |
DNA Primers | 14 | 0.0 |
Hydrolysis | 3 | 0.0 |
Polymerase Chain Reaction | 19 | 0.0 |
Carrier Proteins/genetics/metabolism | 3 | 1.0 |
Chelating Agents/pharmacology | 2 | 2.0 |
Antigens, CD34/analysis | 6 | 0.0 |
Carrier Proteins/*genetics | 3 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Interleukin-3/*pharmacology | 7 | 5.0 |
Prolactin/*pharmacology | 11 | 13.0 |
RNA, Messenger/genetics | 8 | 0.0 |
Recombinant Proteins/pharmacology | 24 | 1.0 |
src Homology Domains | 26 | 4.0 |
Gene Expression/drug effects | 7 | 0.0 |
Insulin-Like Growth Factor I/genetics | 2 | 9.0 |
Liver/drug effects/metabolism | 2 | 2.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Oncogene Proteins, Fusion/metabolism | 2 | 13.0 |
Antibodies/pharmacology | 4 | 1.0 |
Cell Count | 2 | 0.0 |
Cell Division/*drug effects | 7 | 2.0 |
Culture Media, Serum-Free | 2 | 0.0 |
DNA/biosynthesis | 6 | 1.0 |
Drug Synergism | 10 | 0.0 |
Indoles/pharmacology | 5 | 2.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors | 3 | 5.0 |
Pertussis Toxin | 3 | 1.0 |
Protein Kinase C/antagonists & inhibitors | 5 | 3.0 |
Rabbits | 11 | 0.0 |
Virulence Factors, Bordetella/pharmacology | 5 | 2.0 |
Receptors, Somatotropin/*physiology | 5 | 62.0 |
Receptor Cross-Talk/physiology | 2 | 20.0 |
Sequence Deletion | 19 | 0.0 |
Protein-Tyrosine Kinase/*analysis | 2 | 6.0 |
Trans-Activators/*analysis | 2 | 8.0 |
Interleukin-6/*physiology | 5 | 6.0 |
Biological Transport | 3 | 0.0 |
*Endocytosis | 2 | 1.0 |
Receptors, Somatotropin/chemistry/genetics/*metabolism | 3 | 75.0 |
Recombinant Proteins/chemistry/metabolism | 6 | 0.0 |
Signal Transduction/drug effects/*physiology | 12 | 5.0 |
Ubiquitins/*metabolism | 2 | 1.0 |
MAP Kinase Kinase 1 | 6 | 3.0 |
MAP Kinase Signaling System/drug effects | 4 | 4.0 |
Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors | 2 | 4.0 |
Neoplasm Proteins/*metabolism | 4 | 0.0 |
Protein Processing, Post-Translational/*drug effects | 6 | 11.0 |
Protein-Serine-Threonine Kinases/antagonists & inhibitors | 4 | 4.0 |
Transforming Growth Factor beta/*pharmacology | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 7 | 2.0 |
Kidney | 6 | 1.0 |
Leptin/*pharmacology | 3 | 10.0 |
Phosphoproteins/*physiology | 2 | 2.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 2 | 0.0 |
Cell Adhesion Molecules/*metabolism | 2 | 0.0 |
Cytoskeletal Proteins/metabolism | 4 | 1.0 |
Hematopoietic Stem Cells/*physiology | 3 | 2.0 |
Nuclear Proteins/metabolism | 5 | 0.0 |
Protein Kinases/metabolism | 5 | 1.0 |
Antineoplastic Agents/therapeutic use | 2 | 0.0 |
Carrier Proteins/*genetics/metabolism | 2 | 0.0 |
Tyrphostins/therapeutic use | 2 | 100.0 |
DNA-Binding Proteins/genetics/physiology | 2 | 2.0 |
Carrier Proteins/metabolism | 6 | 0.0 |
Cytokines/*metabolism | 7 | 2.0 |
Electrophoresis, Polyacrylamide Gel | 12 | 0.0 |
Growth Hormone/*metabolism | 11 | 21.0 |
Immunoprecipitation | 2 | 0.0 |
RNA/metabolism | 2 | 0.0 |
Recombinant Proteins/chemistry | 3 | 0.0 |
Breast Neoplasms | 3 | 1.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
DNA-Binding Proteins/metabolism/*physiology | 4 | 3.0 |
Plasmids | 2 | 0.0 |
Trans-Activators/metabolism/*physiology | 4 | 6.0 |
Human Growth Hormone/pharmacology | 5 | 29.0 |
Lipopolysaccharides/*pharmacology | 2 | 0.0 |
RNA, Messenger/biosynthesis | 7 | 0.0 |
Transcription, Genetic/*drug effects | 4 | 1.0 |
Calcium/*metabolism | 3 | 0.0 |
Hematopoiesis/physiology | 2 | 4.0 |
Comparative Study | 32 | 0.0 |
Consensus Sequence | 5 | 0.0 |
Conserved Sequence | 4 | 0.0 |
Homeostasis | 2 | 0.0 |
Models, Molecular | 7 | 0.0 |
Protein-Tyrosine Kinase/*chemistry | 3 | 15.0 |
Sequence Alignment | 7 | 0.0 |
Protein-Tyrosine Kinase/*immunology | 2 | 13.0 |
Binding Sites | 23 | 0.0 |
Chimeric Proteins/metabolism | 4 | 2.0 |
Mutagenesis | 10 | 0.0 |
Oncogene Proteins, Fusion/*metabolism | 2 | 10.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
Leukemia/pathology | 3 | 9.0 |
Piperazines/*pharmacology | 2 | 3.0 |
Pyrimidines/*pharmacology | 3 | 4.0 |
Biological Transport/drug effects | 2 | 0.0 |
Cell Nucleus/drug effects/metabolism | 2 | 3.0 |
Muscle, Smooth, Vascular/cytology/drug effects/metabolism | 2 | 28.0 |
Transduction, Genetic | 2 | 0.0 |
Cell Line, Transformed | 6 | 0.0 |
Fluorescent Antibody Technique | 6 | 0.0 |
Trans-Activators | 2 | 4.0 |
Child, Preschool | 6 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Interleukin-6/pharmacology | 7 | 2.0 |
Interferon-gamma, Recombinant/*pharmacology | 5 | 3.0 |
Molecular Weight | 10 | 0.0 |
Quinones/pharmacology | 4 | 2.0 |
Apoptosis/drug effects/physiology | 2 | 2.0 |
Cell Adhesion/drug effects | 2 | 0.0 |
Transcription Factors/physiology | 3 | 1.0 |
Transcription, Genetic/drug effects/physiology | 2 | 5.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors | 2 | 2.0 |
Animals, Newborn | 2 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors | 2 | 7.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Insulin/biosynthesis | 2 | 25.0 |
Receptors, Prolactin/genetics | 2 | 40.0 |
Trans-Activators/genetics/*physiology | 2 | 2.0 |
Calcium/metabolism | 9 | 0.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 4 | 1.0 |
Protein-Tyrosine Kinase/genetics | 5 | 4.0 |
Sheep | 6 | 1.0 |
Interleukin-13/*pharmacology | 4 | 8.0 |
Interleukin-4/*pharmacology | 8 | 3.0 |
Signal Transduction/*drug effects/physiology | 2 | 3.0 |
Trans-Activators/antagonists & inhibitors/*metabolism | 2 | 8.0 |
Mice, Inbred C57BL | 6 | 0.0 |
Signal Transduction/genetics/*immunology | 4 | 4.0 |
Immunosorbent Techniques | 9 | 3.0 |
Receptors, Somatotropin/genetics/*metabolism | 4 | 28.0 |
Tetradecanoylphorbol Acetate/pharmacology | 5 | 0.0 |
DNA/genetics/metabolism | 5 | 1.0 |
Interleukin-6/*antagonists & inhibitors/pharmacology | 2 | 33.0 |
Mutation/genetics | 2 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 2 | 1.0 |
Protein-Tyrosine-Phosphatase/antagonists & inhibitors/metabolism | 2 | 14.0 |
*Receptor Cross-Talk | 2 | 14.0 |
rhoA GTP-Binding Protein/metabolism | 2 | 2.0 |
Gene Expression Regulation, Enzymologic/drug effects/*physiology | 2 | 7.0 |
Genes, ras | 4 | 1.0 |
Isoenzymes/genetics/*metabolism | 2 | 2.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Cattle | 8 | 0.0 |
Lymphokines/*pharmacology | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 2 | 0.0 |
Lymphokines/pharmacology | 4 | 2.0 |
Peptides/*pharmacology | 5 | 2.0 |
Carrier Proteins/chemistry/genetics/*metabolism | 3 | 2.0 |
Receptor, Insulin/metabolism | 6 | 7.0 |
Binding, Competitive | 4 | 0.0 |
Protein-Tyrosine Kinase/genetics/metabolism | 3 | 4.0 |
Cell Division/physiology | 6 | 0.0 |
Crystallography, X-Ray | 2 | 0.0 |
Gene Expression Regulation | 18 | 0.0 |
Human Growth Hormone/chemistry/*physiology | 2 | 100.0 |
Protein Processing, Post-Translational | 11 | 1.0 |
Phenylalanine | 3 | 11.0 |
Receptors, Somatotropin/chemistry/genetics/*physiology | 2 | 66.0 |
Recombinant Proteins/metabolism/pharmacology | 4 | 3.0 |
Enzyme Inhibitors/metabolism | 3 | 1.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology | 8 | 2.0 |
Androstadienes/pharmacology | 4 | 1.0 |
Densitometry | 2 | 1.0 |
Signal Transduction/drug effects/genetics | 3 | 8.0 |
Transfection/genetics | 2 | 1.0 |
Apoptosis/*drug effects | 2 | 0.0 |
Cell Survival/drug effects | 7 | 0.0 |
*Proto-Oncogene Proteins c-bcl-2 | 2 | 0.0 |
Stem Cell Factor/*pharmacology | 4 | 6.0 |
Gene Expression Regulation/drug effects | 8 | 0.0 |
Interleukin-2/pharmacology | 6 | 1.0 |
Receptors, Erythropoietin/genetics/metabolism | 2 | 18.0 |
Exons | 3 | 0.0 |
Introns | 3 | 0.0 |
Luciferases/genetics/metabolism | 2 | 0.0 |
Phylogeny | 3 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 6 | 2.0 |
Regulatory Sequences, Nucleic Acid | 4 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Immunohistochemistry | 9 | 0.0 |
Maleimides/pharmacology | 2 | 2.0 |
Proteins/physiology | 2 | 1.0 |
Infant | 4 | 0.0 |
Depression, Chemical | 2 | 1.0 |
Interleukin-6/metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors | 9 | 5.0 |
Signal Transduction/drug effects/immunology | 2 | 4.0 |
Peptide Mapping | 4 | 0.0 |
Receptors, Cytokine/physiology | 3 | 11.0 |
Receptors, Prolactin/physiology | 2 | 22.0 |
Cell Culture Techniques | 2 | 0.0 |
Eosinophils/*immunology | 3 | 5.0 |
DNA, Complementary | 12 | 0.0 |
CHO Cells | 24 | 1.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Leukocyte Count | 2 | 0.0 |
Carcinoma, Hepatocellular/metabolism | 2 | 2.0 |
Insulin/*pharmacology | 6 | 2.0 |
Insulin-Like Growth Factor I/pharmacology | 2 | 1.0 |
*Transcription, Genetic | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis | 2 | 2.0 |
Proto-Oncogene Proteins c-fos/metabolism | 2 | 1.0 |
Receptors, Somatotropin/chemistry/*metabolism | 3 | 50.0 |
Trans-Activators/biosynthesis | 2 | 5.0 |
Dexamethasone/pharmacology | 3 | 0.0 |
Growth Hormone/pharmacology | 4 | 11.0 |
Receptors, Interleukin-6/genetics/*metabolism | 2 | 66.0 |
Stimulation, Chemical | 4 | 0.0 |
Cricetulus | 2 | 0.0 |
Macromolecular Substances | 18 | 0.0 |
Recombinant Fusion Proteins/physiology | 3 | 1.0 |
*Cell Transformation, Neoplastic | 3 | 0.0 |
Cytoplasm/metabolism | 6 | 0.0 |
Genes, fos | 6 | 5.0 |
Embryo | 2 | 0.0 |
Insulin-Like Growth Factor I/*pharmacology | 2 | 1.0 |
Cell Adhesion | 6 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/metabolism/*physiology | 3 | 25.0 |
Tissue Distribution | 4 | 0.0 |
Receptors, Interferon/metabolism | 5 | 12.0 |
U937 Cells | 3 | 0.0 |
1-Phosphatidylinositol 3-Kinase/physiology | 2 | 1.0 |
Interferon-gamma, Recombinant/pharmacology | 4 | 2.0 |
*Protein Biosynthesis | 4 | 0.0 |
Models, Genetic | 2 | 0.0 |
Cytokines/metabolism | 3 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 3 | 1.0 |
Interleukin-3/metabolism | 2 | 6.0 |
Transcription Factors/chemistry/*metabolism | 3 | 2.0 |
*Genes, myc | 3 | 1.0 |
Interleukin-2/*pharmacology | 5 | 1.0 |
Thrombin/*pharmacology | 3 | 2.0 |
Up-Regulation/drug effects | 2 | 0.0 |
Hodgkin Disease/*genetics | 2 | 11.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Signal Transduction/genetics | 2 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/metabolism | 2 | 6.0 |
Protein-Tyrosine Kinase/chemistry/metabolism | 2 | 12.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinases/genetics/*metabolism | 2 | 4.0 |
Angiotensin II/*physiology | 4 | 11.0 |
DNA-Binding Proteins/*biosynthesis | 2 | 1.0 |
Enzyme Induction | 5 | 0.0 |
NADPH Oxidase/*physiology | 2 | 28.0 |
Protein-Tyrosine Kinase/*biosynthesis | 5 | 20.0 |
Reactive Oxygen Species/metabolism | 5 | 1.0 |
Trans-Activators/*biosynthesis | 2 | 3.0 |
Receptors, Interleukin/*metabolism | 5 | 15.0 |
Tyrosine/genetics/metabolism | 2 | 10.0 |
DNA-Binding Proteins/biosynthesis/*metabolism | 2 | 3.0 |
Trans-Activators/biosynthesis/*metabolism | 2 | 13.0 |
Lymphocyte Activation/*drug effects | 2 | 0.0 |
Carcinoma, Hepatocellular | 3 | 0.0 |
*Growth Inhibitors | 2 | 3.0 |
*Interleukin-6 | 5 | 1.0 |
*Lymphokines | 2 | 4.0 |
Hypophysectomy | 3 | 5.0 |
Proteins/*metabolism | 15 | 1.0 |
Rats, Inbred F344 | 3 | 0.0 |
Receptors, Somatotropin/drug effects/*physiology | 2 | 66.0 |
Liver/*metabolism | 4 | 0.0 |
Carrier Proteins/genetics | 2 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Point Mutation | 5 | 0.0 |
Cytokines/physiology | 4 | 2.0 |
Erythroid Progenitor Cells/*cytology | 2 | 10.0 |
Erythropoietin/physiology | 2 | 16.0 |
Alleles | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Species Specificity | 3 | 0.0 |
Leptin/*physiology | 2 | 18.0 |
Proteins/genetics/*physiology | 3 | 2.0 |
Enzyme Activation/genetics | 3 | 3.0 |
*Genes, fos | 2 | 3.0 |
Protein-Tyrosine Kinase/analysis/*metabolism | 2 | 28.0 |
Receptors, Somatotropin/*metabolism | 4 | 20.0 |
Pedigree | 2 | 0.0 |
Receptors, Erythropoietin/*genetics | 2 | 7.0 |
Prolactin/*metabolism | 3 | 5.0 |
Proteins/genetics/metabolism | 2 | 1.0 |
*Trans-Activators | 2 | 0.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 2 | 0.0 |
DNA, Complementary/genetics | 6 | 0.0 |
Diagnosis, Differential | 2 | 0.0 |
*src Homology Domains | 6 | 3.0 |
Cell Differentiation/drug effects/physiology | 2 | 2.0 |
Granulocyte Colony-Stimulating Factor/*pharmacology | 4 | 3.0 |
Receptors, Granulocyte Colony-Stimulating Factor/*physiology | 2 | 33.0 |
Enzyme Activation/immunology | 4 | 3.0 |
*Mitogen-Activated Protein Kinases | 7 | 2.0 |
*Apoptosis | 4 | 0.0 |
Computer Simulation | 2 | 0.0 |
Drug Design | 2 | 0.0 |
Quinazolines/*pharmacology | 2 | 2.0 |
Age Factors | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 14 | 4.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/metabolism | 2 | 3.0 |
Interleukin-2/metabolism | 2 | 1.0 |
Mitogen-Activated Protein Kinase 1 | 4 | 3.0 |
Protein Biosynthesis | 3 | 0.0 |
Transcription Factors/biosynthesis | 3 | 3.0 |
Cyclins/genetics/metabolism | 2 | 3.0 |
Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Neutrophils/*enzymology | 2 | 1.0 |
Phosphotyrosine/blood | 3 | 33.0 |
Molecular Structure | 2 | 0.0 |
Recombinant Fusion Proteins/genetics | 2 | 1.0 |
Proteins/*physiology | 4 | 2.0 |
Proto-Oncogene Proteins/*physiology | 2 | 0.0 |
Receptors, Erythropoietin/metabolism | 7 | 22.0 |
*Ubiquitin-Protein Ligases | 5 | 0.0 |
Proteins/genetics/*metabolism | 3 | 0.0 |
Receptors, Granulocyte Colony-Stimulating Factor/*genetics | 2 | 33.0 |
Receptors, Interleukin/chemistry/*physiology | 2 | 66.0 |
Antineoplastic Agents/*pharmacology/therapeutic use | 2 | 2.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/physiology | 2 | 7.0 |
src-Family Kinases/*antagonists & inhibitors | 2 | 12.0 |
Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Protein Kinase C/metabolism | 4 | 0.0 |
Stress, Mechanical | 2 | 0.0 |
Granulocyte Colony-Stimulating Factor/*metabolism | 2 | 22.0 |
Hematopoiesis | 4 | 1.0 |
Proto-Oncogene Proteins/*metabolism | 10 | 0.0 |
Genes, fos/genetics | 3 | 6.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*physiology | 3 | 16.0 |
Signal Transduction/*immunology | 6 | 1.0 |
DNA Primers/genetics | 3 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 4 | 0.0 |
Thrombopoietin/*metabolism | 2 | 7.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Receptors, Somatotropin/genetics/metabolism | 3 | 50.0 |
Aorta | 2 | 1.0 |
Histocompatibility Antigens Class I/biosynthesis | 2 | 4.0 |
Carrier Proteins/*pharmacology | 2 | 4.0 |
Gene Expression Regulation, Leukemic | 2 | 2.0 |
Neoplasm Proteins/physiology | 2 | 3.0 |
Tumor Cells, Cultured/drug effects | 3 | 0.0 |
Genes, MHC Class II | 2 | 0.0 |
Antiviral Agents/*pharmacology | 2 | 1.0 |
HL-60 Cells | 5 | 0.0 |
Suppression, Genetic | 2 | 3.0 |
Lymphocyte Activation/drug effects | 2 | 0.0 |
In Vitro | 10 | 0.0 |
Cell Membrane/chemistry | 2 | 1.0 |
Protein Conformation | 9 | 0.0 |
Human Growth Hormone/*metabolism | 2 | 15.0 |
Pregnancy | 2 | 0.0 |
Mammals | 3 | 0.0 |
Receptors, Cytokine/*physiology | 4 | 15.0 |
Binding Sites/genetics | 2 | 0.0 |
Human Growth Hormone/genetics/*metabolism | 2 | 66.0 |
Interferon-alpha/*pharmacology | 5 | 3.0 |
Lymphocyte Activation | 3 | 0.0 |
Recombinant Proteins/biosynthesis | 3 | 0.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 2 | 1.0 |
Interleukin-13/pharmacology/*physiology | 2 | 28.0 |
Mice, Mutant Strains | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/genetics/*metabolism | 3 | 6.0 |
Clone Cells | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism/*physiology | 3 | 11.0 |
Proteins/metabolism/*physiology | 2 | 4.0 |
Receptors, Interleukin/biosynthesis | 3 | 18.0 |
Half-Life | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 7 | 2.0 |
Antigens, CD/chemistry/*physiology | 2 | 14.0 |
Chimeric Proteins/chemistry/metabolism | 3 | 5.0 |
Interleukin-6/pharmacology/*physiology | 2 | 18.0 |
Liver Neoplasms | 2 | 0.0 |
Membrane Glycoproteins/chemistry/*physiology | 2 | 13.0 |
Erythropoietin/biosynthesis/genetics/*physiology | 2 | 100.0 |
Human Growth Hormone/pharmacology/*physiology | 2 | 66.0 |
Receptor, Epidermal Growth Factor/*metabolism | 6 | 0.0 |
Luciferases/genetics | 4 | 1.0 |
Peptide Fragments/chemistry/immunology | 2 | 3.0 |
Recombinant Fusion Proteins/biosynthesis | 4 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Interleukin-6/*pharmacology | 6 | 2.0 |
Trans-Activators/*genetics/metabolism | 3 | 2.0 |
Eosinophils/physiology | 2 | 15.0 |
*Hematopoiesis | 3 | 1.0 |
Interleukin-5/*physiology | 3 | 33.0 |
Cell Differentiation/physiology | 3 | 0.0 |
Isomerism | 2 | 0.0 |
Oxidation-Reduction | 3 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
*Trans-Activation (Genetics) | 4 | 0.0 |
B-Lymphocytes/*physiology | 2 | 1.0 |
Antigens, CD/*metabolism | 4 | 0.0 |
Membrane Glycoproteins/*metabolism | 3 | 0.0 |
Receptors, Interleukin/*physiology | 4 | 16.0 |
*Tyrphostins | 3 | 5.0 |
Erythropoietin/metabolism/*pharmacology | 2 | 66.0 |
Child | 5 | 0.0 |
Antineoplastic Agents/*therapeutic use | 2 | 0.0 |
Blotting, Western/methods | 2 | 1.0 |
Antibodies, Monoclonal/immunology | 2 | 0.0 |
Lymphocyte Activation/*physiology | 2 | 2.0 |
Gene Library | 5 | 0.0 |
Solubility | 2 | 0.0 |
Interferon Type II/*antagonists & inhibitors/pharmacology | 2 | 66.0 |
GTP-Binding Proteins/*metabolism | 2 | 0.0 |
Gene Expression Regulation/*drug effects | 6 | 0.0 |
Growth Inhibitors/pharmacology | 3 | 2.0 |
Umbilical Veins | 2 | 0.0 |
Interleukin-5/*metabolism | 2 | 25.0 |
Jurkat Cells | 2 | 0.0 |
Receptors, Prolactin/metabolism | 2 | 12.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Liver Neoplasms, Experimental/metabolism | 2 | 10.0 |
Protein Synthesis Inhibitors/pharmacology | 2 | 0.0 |
Baculoviridae/genetics | 3 | 1.0 |
Protein-Tyrosine Kinase/chemistry/genetics/*metabolism | 2 | 8.0 |
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/physiology | 2 | 50.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 4 | 1.0 |
Chickens | 2 | 0.0 |
Receptors, Granulocyte Colony-Stimulating Factor/metabolism | 2 | 16.0 |
*Gene Expression Regulation | 6 | 0.0 |
Interferon Type II/*physiology | 5 | 7.0 |
Proto-Oncogene Protein p21(ras)/metabolism | 3 | 3.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 3 | 0.0 |
Spodoptera | 4 | 1.0 |
Neutrophils/*metabolism | 3 | 1.0 |
Protein-Tyrosine Kinase/*chemistry/genetics/*metabolism | 2 | 11.0 |
Tyrosine/chemistry | 6 | 4.0 |
Receptors, Cell Surface/*metabolism | 2 | 0.0 |
Receptors, Prolactin/genetics/*metabolism | 3 | 50.0 |
Staurosporine/pharmacology | 4 | 2.0 |
Chimeric Proteins | 2 | 2.0 |
Biopolymers | 2 | 1.0 |
Translocation, Genetic | 2 | 0.0 |
Proto-Oncogene Protein c-kit/*metabolism | 3 | 6.0 |
Trans-Activators/chemistry/*metabolism | 2 | 3.0 |
Alternative Splicing | 2 | 0.0 |
Antibodies/immunology | 2 | 0.0 |
Erythropoietin, Recombinant/*pharmacology | 2 | 8.0 |
Receptors, Angiotensin/antagonists & inhibitors | 2 | 4.0 |
Models, Structural | 2 | 1.0 |
Cyclic AMP/metabolism | 2 | 0.0 |
Growth Hormone/metabolism | 2 | 4.0 |
Protein-Serine-Threonine Kinases/*metabolism | 3 | 0.0 |
Serine/chemistry | 2 | 1.0 |
1-Phosphatidylinositol 3-Kinase | 8 | 5.0 |
Interferons/*pharmacology | 2 | 2.0 |
Phosphotransferases (Alcohol Group Acceptor)/metabolism | 4 | 5.0 |
Receptor, IGF Type 1/metabolism | 2 | 6.0 |
Antibodies, Monoclonal/pharmacology | 2 | 0.0 |
Antigens, CD/immunology | 2 | 0.0 |
Monocytes/*metabolism | 3 | 0.0 |
Receptors, IgG/*biosynthesis/genetics | 2 | 50.0 |
*Mutation | 2 | 0.0 |
Rats, Inbred Lew | 2 | 0.0 |
Receptors, Somatotropin/genetics | 2 | 14.0 |
Culture Media | 2 | 0.0 |
Fibrosarcoma | 3 | 6.0 |
Recombinant Proteins/biosynthesis/pharmacology | 2 | 6.0 |
Cell Nucleus/*enzymology | 2 | 5.0 |
Mitogen-Activated Protein Kinase Kinases | 2 | 5.0 |
Nitric Oxide/metabolism | 3 | 1.0 |
Receptors, Prolactin/genetics/metabolism | 2 | 40.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Epidermal Growth Factor/pharmacology | 5 | 0.0 |
Interferon-beta/*pharmacology | 4 | 6.0 |
*Mitogen-Activated Protein Kinase Kinases | 2 | 2.0 |
Proto-Oncogene Proteins c-raf | 3 | 2.0 |
Proto-Oncogene Proteins c-fos/genetics | 2 | 3.0 |
*Cell Cycle Proteins | 6 | 0.0 |
Phosphotransferases (Alcohol Group Acceptor)/*metabolism | 4 | 4.0 |
Proline | 3 | 5.0 |
Protein-Tyrosine Kinase/*genetics/metabolism | 4 | 8.0 |
Trans-Activators/*genetics | 2 | 0.0 |
Receptors, Interleukin-3/*metabolism | 2 | 28.0 |
Receptors, Interleukin-6 | 4 | 4.0 |
Cell Adhesion Molecules/isolation & purification/*metabolism | 2 | 50.0 |
Protein-Tyrosine Kinase/isolation & purification/*metabolism | 7 | 35.0 |
Proto-Oncogene Proteins/genetics/metabolism | 2 | 1.0 |
Receptors, Interleukin-4 | 7 | 10.0 |
Recombinant Proteins/biosynthesis/isolation & purification/metabolism | 2 | 3.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/*metabolism | 2 | 3.0 |
Enzyme Activation/physiology | 3 | 1.0 |
Thrombopoietin/*pharmacology | 11 | 11.0 |
Interleukin-4/*physiology | 2 | 4.0 |
T-Lymphocytes | 3 | 1.0 |
Mitosis/drug effects | 2 | 1.0 |
Protein Kinases/*metabolism | 2 | 0.0 |
Glycosylation | 2 | 0.0 |
Adipocytes/drug effects/*metabolism | 2 | 15.0 |
Cytokines/*pharmacology | 9 | 2.0 |
Receptors, Interleukin-3/*physiology | 2 | 100.0 |
Lipids/biosynthesis | 2 | 10.0 |
Luciferases/biosynthesis | 3 | 3.0 |
Growth Hormone/*metabolism/pharmacology | 2 | 50.0 |
Receptors, Interleukin-7 | 2 | 11.0 |
Proteins/chemistry | 2 | 4.0 |
Son of Sevenless Proteins | 3 | 5.0 |
Receptor, Epidermal Growth Factor/metabolism | 4 | 0.0 |
Peptides/*genetics | 2 | 2.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
B-Lymphocytes/drug effects/immunology/*physiology | 2 | 40.0 |
Thymidine/metabolism | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Proto-Oncogene Proteins/antagonists & inhibitors | 3 | 17.0 |
DNA-Binding Proteins/isolation & purification/*metabolism | 3 | 4.0 |
Phosphoproteins/isolation & purification/*metabolism | 4 | 12.0 |
Proteins/isolation & purification/*metabolism | 3 | 9.0 |
Trans-Activators/isolation & purification/*metabolism | 2 | 15.0 |
Interleukin-12/*pharmacology | 3 | 6.0 |
Serine/metabolism | 2 | 0.0 |
*Protein Processing, Post-Translational/drug effects | 2 | 11.0 |
Sequence Homology, Nucleic Acid | 5 | 0.0 |
Blood Platelets/drug effects/*enzymology | 2 | 15.0 |
Platelet Activation/*drug effects | 2 | 3.0 |
Platelet Aggregation/drug effects | 2 | 0.0 |
Thrombin/pharmacology | 2 | 0.0 |
Culture Media, Serum-Free/pharmacology | 2 | 1.0 |
Growth Hormone/metabolism/*pharmacology | 2 | 50.0 |
Cross-Linking Reagents | 2 | 0.0 |
Oligonucleotide Probes | 3 | 0.0 |
Interferon-alpha/pharmacology | 3 | 3.0 |
Phosphoproteins/isolation & purification/metabolism | 7 | 20.0 |
Hematopoietic Stem Cells | 2 | 3.0 |
Oligodeoxyribonucleotides | 8 | 0.0 |
Oligodeoxyribonucleotides/chemistry | 2 | 0.0 |
Cytoplasm | 2 | 3.0 |
HIV-1/*physiology | 2 | 0.0 |
Aspirin/pharmacology | 2 | 3.0 |
Blood Platelets/*drug effects/metabolism | 2 | 5.0 |
Platelet Aggregation Inhibitors/pharmacology | 2 | 3.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Cell Nucleus/physiology | 2 | 2.0 |
Phosphoproteins/analysis | 2 | 5.0 |
*Antigens, CD | 2 | 0.0 |
Receptors, Somatotropin/*chemistry/genetics/*physiology | 2 | 100.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Angiotensin II/*pharmacology | 4 | 3.0 |
Cytosol/metabolism | 2 | 0.0 |
Interleukin-11/*pharmacology | 2 | 12.0 |
Intercellular Adhesion Molecule-1/metabolism | 2 | 1.0 |
Catalysis | 4 | 0.0 |
Receptors, Interleukin-2/*metabolism | 2 | 2.0 |
T-Lymphocytes/*metabolism | 2 | 0.0 |
Phosphotyrosine | 24 | 9.0 |
*Tyrosine/analogs & derivatives/metabolism | 2 | 66.0 |
Recombinant Proteins/biosynthesis/metabolism/pharmacology | 4 | 33.0 |
Cercopithecus aethiops | 5 | 0.0 |
*Protein Kinase Inhibitors | 2 | 3.0 |
Staurosporine | 3 | 3.0 |
Interleukin-4/pharmacology | 3 | 0.0 |
Tyrosine/analogs & derivatives/analysis | 4 | 10.0 |
Tyrosine/analogs & derivatives/metabolism | 10 | 8.0 |
Interleukin-3/*physiology | 3 | 20.0 |
Oligonucleotides, Antisense/pharmacology | 3 | 1.0 |
Angiotensin II/*metabolism | 2 | 4.0 |
Epidermal Growth Factor/metabolism | 2 | 0.0 |
Colony-Forming Units Assay | 3 | 0.0 |
Erythropoietin, Recombinant/pharmacology | 2 | 25.0 |
Aurintricarboxylic Acid/*pharmacology | 2 | 22.0 |
Linkage (Genetics) | 2 | 0.0 |
Tyrosine/*analogs & derivatives/metabolism | 2 | 3.0 |
Transcription, Genetic/drug effects | 4 | 0.0 |
Stem Cell Factor | 3 | 3.0 |
Alkaloids/pharmacology | 2 | 1.0 |
Antibodies, Monoclonal | 3 | 0.0 |
Receptors, Somatotropin/analysis/genetics/*metabolism | 2 | 100.0 |
Protein Binding/drug effects | 2 | 0.0 |
Receptors, Erythropoietin/biosynthesis/*physiology | 2 | 40.0 |
Chromosome Aberrations | 2 | 0.0 |
Thermodynamics | 2 | 0.0 |
Cell Membrane/*metabolism | 2 | 0.0 |
Tyrosine/*analogs & derivatives/analysis/metabolism | 3 | 33.0 |
Enzyme Induction/drug effects/genetics | 2 | 28.0 |
Protein Transport/drug effects | 2 | 3.0 |
DNA-Binding Proteins/biosynthesis/genetics | 2 | 2.0 |
Trans-Activators/biosynthesis/genetics | 2 | 5.0 |
Receptors, Cytokine/chemistry/*metabolism | 2 | 33.0 |
Muscle, Smooth, Vascular/*cytology | 2 | 9.0 |
rac1 GTP-Binding Protein/metabolism | 2 | 2.0 |
Mitogen-Activated Protein Kinase 1/*metabolism | 2 | 1.0 |
Protein-Tyrosine-Phosphatase/genetics/*physiology | 3 | 25.0 |
Epithelial Cells/cytology | 2 | 2.0 |
Karyotyping | 2 | 0.0 |
MAP Kinase Signaling System/*drug effects | 2 | 5.0 |
Phosphoserine/metabolism | 2 | 2.0 |
Aorta/cytology | 2 | 2.0 |
Electroporation | 2 | 3.0 |
Vasoconstrictor Agents/*pharmacology | 2 | 5.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/*metabolism | 2 | 2.0 |
Acetophenones/pharmacology | 3 | 13.0 |
Caspases/metabolism | 2 | 0.0 |
*Drug Design | 2 | 2.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Active Transport, Cell Nucleus | 2 | 0.0 |
Receptor, erbB-2/metabolism | 2 | 1.0 |
Collagen Type II/*genetics | 2 | 9.0 |
Guanosine Triphosphate/metabolism | 2 | 0.0 |
